Atlas Trials

Sorafenib With Capecitabine for Patients With Measurable Hepatocellular Carcinoma

Clinical trial NCT01032850 · TERMINATED

Trial details

NCT number
NCT01032850
Sponsor
New Mexico Cancer Research Alliance
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2009-09-01
Primary completion
2012-05-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.